Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.
Concentrations of circulating immune complexes (CIC) were measured serially during chemotherapy of 22 patients with gestational trophoblastic tumours (GTT) and 11 patients with malignant teratoma (MT) by the polyethylene glycol precipitation and CIq solid-phase assays. Results were correlated with t...
Main Authors: | Begent, R. H., Chester, K. A., Walker, L. C., Tucker, D. F. |
---|---|
Format: | Online |
Language: | English |
Published: |
1982
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010888/ |
Similar Items
-
Tumour-marker levels and prognosis in malignant teratoma of the testis.
by: Germa-Lluch, J. R., et al.
Published: (1980) -
Chemotherapy of advanced malignant teratomas.
by: Newlands, E. S., et al.
Published: (1980) -
Doppler assessment of the uterine circulation and the clinical behaviour of gestational trophoblastic tumours requiring chemotherapy.
by: Long, M. G., et al.
Published: (1992) -
A serum factor with potential as a tumour marker in malignant lymphoma.
by: Begent, R. H., et al.
Published: (1980) -
Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours.
by: Shi, Y. F., et al.
Published: (1996)